Angus M. MacLeod

3.2k total citations
62 papers, 2.4k citations indexed

About

Angus M. MacLeod is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Angus M. MacLeod has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 26 papers in Organic Chemistry and 26 papers in Cellular and Molecular Neuroscience. Recurrent topics in Angus M. MacLeod's work include Neuroscience and Neuropharmacology Research (13 papers), Receptor Mechanisms and Signaling (13 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). Angus M. MacLeod is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Receptor Mechanisms and Signaling (13 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). Angus M. MacLeod collaborates with scholars based in United Kingdom, United States and Belgium. Angus M. MacLeod's co-authors include Kevin J. Merchant, R. BAKER, John Saunders, Margaret A. Cascieri, Alan P. Watt, John Atack, Nigel S. Simpkins, David A. Price, Gerard R. Dawson and Sharon Sadowski and has published in prestigious journals such as Journal of Biological Chemistry, Brain and Annals of the New York Academy of Sciences.

In The Last Decade

Angus M. MacLeod

59 papers receiving 2.3k citations

Peers

Countries citing papers authored by Angus M. MacLeod

Since Specialization

Citations

This map shows the geographic impact of Angus M. MacLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angus M. MacLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angus M. MacLeod more than expected).

Fields of papers citing papers by Angus M. MacLeod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angus M. MacLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angus M. MacLeod. The network helps show where Angus M. MacLeod may publish in the future.

Co-authorship network of co-authors of Angus M. MacLeod

This figure shows the co-authorship network connecting the top 25 collaborators of Angus M. MacLeod. A scholar is included among the top collaborators of Angus M. MacLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angus M. MacLeod. Angus M. MacLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models 2025 ·Brain ·Eduardo A. Albornoz, Karine Mardon, Rajiv Bhalla, Vinod Kumar, (unknown), Gary Cowin, (unknown), Mark S. Butler, Ruby Pelingon, Richard D. Gordon, Rebecca C. Coll, Kate Schroder, Reena Halai, Angus M. MacLeod, Kim L. Matthews, Avril A. B. Robertson, Matthew A. Cooper, Trent M. Woodruff	0
2	Discovery of ONO-8590580: A novel, potent and selective GABAA α5 negative allosteric modulator for the treatment of cognitive disorders 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Alan Beresford, Mark S. Chambers, (unknown), (unknown), (unknown), (unknown), (unknown), Miki Nakanishi, (unknown), (unknown), Hiromu Habashita, (unknown), Angus M. MacLeod, Andrew P. Owens, A. David Rae, (unknown), Graham N. Wishart	1
3	Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Grégory Bar, (unknown), Paul Edwards, Reginald Brys, M.G. Chambers, Wolfgang Schmidt, Angus M. MacLeod, (unknown), (unknown), Véronique Birault, Joelle Le, (unknown), (unknown), Kevin M. Nash, (unknown)	12
4	An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Gerard R. Dawson, Karen Maubach, Neil Collinson, Mark Cobain, Barry J. Everitt, Angus M. MacLeod, Hedaythul Choudhury, Louise McDonald, Gopalan V. Pillai, Wayne Rycroft, Alesha Smith, Francine Sternfeld, F.D. Tattersall, Keith A. Wafford, David S. Reynolds, Guy R. Seabrook, John Atack	207
5	Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction 2005 ·Bioorganic & Medicinal Chemistry Letters ·Philip Jones, John Atack, Matthew P. Braun, (unknown), Mark S. Chambers, Desmond O’Connor, Susan M. Cook, Sarah C. Hobbs, (unknown), (unknown), (unknown), Keith A. Wafford, Angus M. MacLeod	18
6	Selective, Orally Active γ-Aminobutyric Acid _A α5 Receptor Inverse Agonists as Cognition Enhancers 2004 ·Journal of Medicinal Chemistry ·Francine Sternfeld, Robert W. Carling, Richard A. Jelley, (unknown), Kevin J. Merchant, Kevin W. Moore, Austin J. Reeve, Leslie J. Street, Desmond O’Connor, Bindi Sohal, John Atack, Susan M. Cook, Guy R. Seabrook, Keith A. Wafford, F.D. Tattersall, Neil Collinson, Gerard R. Dawson, José L. Castro, Angus M. MacLeod	92
7	Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1 and 5-HT re-uptake ligands 1999 ·Bioorganic & Medicinal Chemistry Letters ·Monique B. van Niel, Margaret S. Beer, (unknown), (unknown), David C. Evans, Anne Heald, Laure Hitzel, Peter Hunt, Russell J. Mortishire‐Smith, Desmond O’Connor, Alan P. Watt, Angus M. MacLeod	10
8	4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT1D agonists for the treatment of migraine 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Joseph G. Neduvelil, Margaret S. Beer, Josephine A. Stanton, Graham A. Showell, Angus M. MacLeod	2
9	Serine derived NK1 antagonists 1: The effect of modifications to the serine substituents 1998 ·Bioorganic & Medicinal Chemistry Letters ·Jason Elliott, Margaret A. Cascieri, Gary G. Chicchi, Stephen J. Davies, Fintan Kelleher, Marc M. Kurtz, T. Ladduwahetty, Richard T. Lewis, Angus M. MacLeod, Kevin J. Merchant, Sharon Sadowski, Graeme I. Stevenson	7
10	[^3H]5‐HT Binding to Cloned Human, Dog, and Rat 5‐HT_1D and 5‐HT_1B Receptors 1998 ·Annals of the New York Academy of Sciences ·Josephine A. Stanton, Luiz Henrique Martins Castro, Angus M. MacLeod, Francine Sternfeld, Leslie J. Street, Margaret S. Beer	0
11	Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets 1996 ·Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, B. Francis, David Pearce, Kevin J. Merchant, Angus M. MacLeod, T. Ladduwahetty, Linda E. Keown, Christopher J. Swain, R. BAKER, Margaret A. Cascieri, E Ber, Joseph M. Metzger, D. Euan MacIntyre, R.G. Hill, Richard Hargreaves	189
12	Tryptophan-Derived NK1 Antagonists: Conformationally Constrained Heterocyclic Bioisosteres of the Ester Linkage 1995 ·Journal of Medicinal Chemistry ·Richard T. Lewis, Angus M. MacLeod, Kevin J. Merchant, Fintan Kelleher, Ian R. Sanderson, Richard H. Herbert, Margaret A. Cascieri, Sharon Sadowski, Richard G. Ball, Karst Hoogsteen	50
13	4,4-Disubstituted Piperidines: A New Class of NK1 Antagonists 1995 ·Journal of Medicinal Chemistry ·Graeme I. Stevenson, Angus M. MacLeod, Ian T. Huscroft, Margaret A. Cascieri, Sharon Sadowski, Raymond Baker	22
14	Synthesis and Biological Evaluation of NK1 Antagonists Derived from L-Tryptophan 1995 ·Journal of Medicinal Chemistry ·Angus M. MacLeod, Margaret A. Cascieri, Kevin J. Merchant, Sharon Sadowski, (unknown), Richard T. Lewis, D. Euan MacIntyre, Joseph M. Metzger, Tung M. Fong	22
15	Identification of L-Tryptophan Derivatives with Potent and Selective Antagonist Activity at the NK1 Receptor 1994 ·Journal of Medicinal Chemistry ·Angus M. MacLeod, Kevin J. Merchant, Frederick A. Brookfield, Fintan Kelleher, Graeme I. Stevenson, Andrew P. Owens, Christopher J. Swain, Margaret A. Cascieri, Sharon Sadowski	52
16	N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists 1993 ·Journal of Medicinal Chemistry ·Angus M. MacLeod, Kevin J. Merchant, Margaret A. Cascieri, Sharon Sadowski, Elżbieta Ber, (unknown), R. BAKER	58
17	Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors 1990 ·Journal of Medicinal Chemistry ·(unknown), R. BAKER, (unknown), Clare O. Kneen, Angus M. MacLeod, Kevin J. Merchant, Graham A. Showell, John Saunders, Richard H. Herbert	116
18	Novel quinuclidine-based ligands for the muscarinic cholinergic receptor 1990 ·Journal of Medicinal Chemistry ·John Saunders, Michael P. Cassidy, (unknown), Elizabeth A. Harley, Leslie L. Iversen, Clare O. Kneen, Angus M. MacLeod, Kevin J. Merchant, Roger J. Snow, Raymond Baker	121
19	Synthesis and muscarinic activities of 1,2,4-thiadiazoles 1990 ·Journal of Medicinal Chemistry ·Angus M. MacLeod, R. BAKER, Ben Freedman, Shil Patel, Kevin J. Merchant, S. Mark Roe, John Saunders	50
20	Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines 1989 ·Journal of Medicinal Chemistry ·Frank Wätjen, R. BAKER, (unknown), Richard H. Herbert, Angus M. MacLeod, Anthony Knight, Kevin J. Merchant, Jonathan D. Moseley, John Saunders, Christopher J. Swain, Erik H.F. Wong, James P. Springer	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact